DK1262186T3 - Azalid antibiotiske kompositioner - Google Patents

Azalid antibiotiske kompositioner

Info

Publication number
DK1262186T3
DK1262186T3 DK02253796T DK02253796T DK1262186T3 DK 1262186 T3 DK1262186 T3 DK 1262186T3 DK 02253796 T DK02253796 T DK 02253796T DK 02253796 T DK02253796 T DK 02253796T DK 1262186 T3 DK1262186 T3 DK 1262186T3
Authority
DK
Denmark
Prior art keywords
antibiotic compositions
azalide antibiotic
compositions
azalide
acids
Prior art date
Application number
DK02253796T
Other languages
Danish (da)
English (en)
Inventor
Wayne A Boettner
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK1262186T3 publication Critical patent/DK1262186T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK02253796T 2001-05-31 2002-05-30 Azalid antibiotiske kompositioner DK1262186T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29467701P 2001-05-31 2001-05-31

Publications (1)

Publication Number Publication Date
DK1262186T3 true DK1262186T3 (da) 2004-07-26

Family

ID=23134451

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02253796T DK1262186T3 (da) 2001-05-31 2002-05-30 Azalid antibiotiske kompositioner

Country Status (12)

Country Link
US (1) US20030092640A1 (de)
EP (1) EP1262186B1 (de)
JP (1) JP2003040782A (de)
AT (1) ATE264684T1 (de)
BR (1) BR0201973A (de)
CA (1) CA2387821A1 (de)
DE (1) DE60200391T2 (de)
DK (1) DK1262186T3 (de)
ES (1) ES2218509T3 (de)
MX (1) MXPA02005381A (de)
PT (1) PT1262186E (de)
TR (1) TR200400954T4 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220422B2 (en) * 2003-05-20 2007-05-22 Allergan, Inc. Methods and compositions for treating eye disorders
JP2007277095A (ja) * 2004-07-02 2007-10-25 Wakamoto Pharmaceut Co Ltd アジスロマイシン含有可逆性熱ゲル化水性組成物
US8078327B2 (en) * 2006-04-04 2011-12-13 Union Plastic (Hangzhou) Machinery Co., Ltd. Control method of a hydraulic machine for saving energy or improving efficiency
EP2098219A1 (de) 2008-03-05 2009-09-09 PARI Pharma GmbH Makrolidzusammensetzungen mit verbessertem Geschmack und verbesserter Stabilität
CA2790895C (en) * 2010-02-24 2016-08-23 Jan Jezek Protein formulations
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN103965273B (zh) * 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN103690560B (zh) * 2013-12-17 2016-08-17 辽宁海思科制药有限公司 一种转化糖电解质注射液药物组合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
BRPI0017013B8 (pt) * 2000-01-27 2022-11-16 Pfizer Prod Inc composição de antibiótico azalídeo e método para sua obtenção
OA12257A (en) * 2000-04-27 2003-11-06 Pfizer Prod Inc the use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals.

Also Published As

Publication number Publication date
ATE264684T1 (de) 2004-05-15
EP1262186A1 (de) 2002-12-04
DE60200391D1 (de) 2004-05-27
EP1262186B1 (de) 2004-04-21
US20030092640A1 (en) 2003-05-15
TR200400954T4 (tr) 2004-07-21
ES2218509T3 (es) 2004-11-16
JP2003040782A (ja) 2003-02-13
CA2387821A1 (en) 2002-11-30
DE60200391T2 (de) 2005-05-04
BR0201973A (pt) 2003-04-22
PT1262186E (pt) 2004-06-30
MXPA02005381A (es) 2002-12-09

Similar Documents

Publication Publication Date Title
NO993996D0 (no) N-heterosykliske derivater som NOS-inhibitorer
CA2398485A1 (en) Azalide antibiotic compositions
NO20020925D0 (no) N-heterosykliske derivater som NOS-inhibitorer
CY1108707T1 (el) Αναλογα νοσισεπτινης
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
EA199900373A2 (ru) Фармацевтические композиции
BR0206155B1 (pt) composiÇÕes copolimÉricas cristalinas de propileno tendo propriedades àpticas e de selagem aperfeiÇoadas e solubilidade reduzida.
NO20034660D0 (no) Spiropyrazolforbindelser
CY1107331T1 (el) Στερεες τυποποιησεις κετιριζινης ταχειας διαλυσης
IT1317716B1 (it) Processo per la preparazione di perfluoropoliossialchileni conterminali ossidrilici.
ATE264684T1 (de) Antibiotische azalid-zusammensetzungen
DK1434779T3 (da) Tværbundne glycopeptid-cephalosporinantibiotika
ITMI20001883A0 (it) Procedimento integrato per la preparazione di epossidi
CY1106376T1 (el) Δικυκλικα παραγωγα των αμινο-πυραζινονων, μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα πepιεχουν
CY1105345T1 (el) Φαινυλαλκινια
ECSP034598A (es) Compuesto lactamico
SV2003000981A (es) Fenil-heterociclil-eteres ref. pcs10973
DK1192139T3 (da) Fremstilling af quinolinsubstituerede carbonat- og carbamatderivater
EA199901056A1 (ru) Усовершенствованный способ для получения противопаразитарного агента
ITRM20000266A0 (it) Procedimento migliorato per la preparazione di (e,z) 3-(2-amminoetossimmino)-androstano-6, 17-dione e di suoi analoghi.
AU2002249863A1 (en) Stabilization of radiopharmaceutical compositions using hydrophilic thioether or a hydrophilic 6-hydroxy chroman
WO2003011266A3 (en) Azalide antibiotic compositions
NO20014755D0 (no) C(7)-karbonatsubstituerte taksaner som antitumormidler
PT1339703E (pt) Processo para a preparacao de paclitaxel
WO2000040589A3 (en) Novel derivatives from the class of oleandomycin